Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 5,133 | 103 | 1,391 | 516 | 312 |
| Gross Profit | 5,133 | 103 | 1,391 | 516 | 312 |
| Operating Expenses | 19,033 | 23,540 | 27,550 | 24,384 | 26,879 |
| Operating Income | -13,900 | -23,437 | -26,159 | -23,868 | -26,567 |
| Interest Expense | 1,043 | 1,079 | 1,088 | 1,070 | 1,086 |
| Other Income | -14,038 | -7,516 | 311 | 410 | 433 |
| Pre-tax Income | -28,981 | -32,032 | -26,936 | -24,528 | -27,220 |
| Net Income Continuous | -28,981 | -32,032 | -26,936 | -24,528 | -27,220 |
| Net Income | $-28,981 | $-32,032 | $-26,936 | $-24,528 | $-27,220 |
| EPS Basic Total Ops | -5.83 | -6.79 | -5.85 | -5.54 | -6.07 |
| EPS Basic Continuous Ops | -5.83 | -6.79 | -5.85 | -5.54 | -6.10 |
| EPS Diluted Total Ops | -5.83 | -6.79 | -5.85 | -5.54 | -6.07 |
| EPS Diluted Continuous Ops | -5.83 | -6.79 | -5.85 | -5.54 | -6.10 |
| EBITDA(a) | $-11,982 | $-21,478 | $-23,993 | $-21,881 | $-24,586 |